medigraphic.com
Anales de la Sociedad Mexicana de Oftalmología y Archivos de la Asociación Para Evitar la Ceguera en México

2018, Number 1

<< Back Next >>

Rev Mex Oftalmol 2018; 92 (1)

Clinical features of secondary retinal vasculitis

Carral-Santander IE, Concha del Rio LE, Cheja-Kalb R, Arellanes-García L

Language: Spanish
References: 33
Page: 50-57
PDF size: 173.34 Kb.


ABSTRACT

Secondary retinal vasculitis are unusual ocular manifestations of several autoimmune diseases, such as granulomatosis with polyangiitis, Behcet disease, sarcoidosis, systemic lupus erythematosus and multiple sclerosis, among others. As a consequence of systemic repercussions the correct diagnosis is of greater importance. The most frequent ophthalmological symptoms are blurry vision and floaters. In some cases highly suggestive ophthalmological signs of certain diseases might be presented, such as retinal periphlebitis also known as “candle wax drippings’’ image of sarcoidosis and the hypophion in Behcet disease. Systemic manifestations are essential for a correct diagnosis, therefore main features of the frequently involved diseases shall be identified.


REFERENCES

  1. Neal V. Ocular manifestations of systemic lupus erythematosus: A review of the literature. Autoinmune Dis. 2012:1-9.

  2. Gonzalez F. Criterios diagnósticos y de clasificación de las enfermedades reumáticas. Guías de práctica clínica Sociedad Española de Reumatología. 2011 [consultado 28Sep 2015]. Disponible en: http://www.ser.es/ practicaClinica/Criterios Diagnosticos.php.

  3. Muscal E, Brey R. Neurological manifestations of systemic lupus erythematosus in children and adults. Neurol Clin.2010;28:61-73.

  4. Graham EM, Stanford MR, Sanders MD, Kasp E, Dumonde DC. A point prevalence study of 150 patients with idiopathic retinal vasculitis: 1. Diagnostic value of ophthalmological features. Br J Ophthalmol. 1989;73:714-21.

  5. Au A, O’Day J. Review of severe vaso-occlusive retinopathy in systemic lupus erythematosus and the antiphospholipid syndrome: Associations, visual outcomes, complications and treatment. Clin Experiment Ophthalmol. 2004;32:87-100.

  6. Yazici A. The biomechanical properties of the cornea in patients with systemic lupus erythematosus. Eye Lond. 2011;25:1005-9.

  7. Hernández JI, Castañeda G, Rodríguez de Romo AC. Esclerosis múltiple en México: la clínica de su historia. Rev Fac Med UNAM. 2006;49:73-8.

  8. Gordon LK. Gender and uveitis in patients with multiple sclerosis. J Ophamol. 2014:1-5.

  9. Perez R, Gomez A. Optic neuritis in pediatric population: A review in current tendencies of diagnosis and mangement. J Optom. 2014;7:125-30.

  10. Chen LG. Ocular manifestations of multiple sclerosis. Curr Opin Ophthalmol. 2005;16:315-20.

  11. Rio J. Retinal periphlebit is in multiple sclerosis. A prospective study. Neurol J. 1993;8:252-5.

  12. Ahmed M. Differential diagnosis of retinal vasculitis. Middle East Afr J Ophthalmol. 2009;16:202-18.

  13. Polman CH. Diagnostic criteria for multiple sclerosis 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69:292-302.

  14. Mackensen F. Interferon therapy for ocular disease. Curr Opin Ophtalmol. 2006;17:567-73.

  15. Davatchi F, Chams D. Adult Behcet’s disease in Iran: Analysis of 6075 patients. Int J Rheum Dis. 2015;10:117.

  16. Al-Araji A, Kidd D. Neuro-Behçet’s disease: Epidemiology, clinical characteristics, and management. Lancet Neurol. 2009;8:192-204.

  17. Michelson JB, Chisari FU. Behcet’s disease. Surv Ophthalmol.1982;26: 190-203.

  18. Tugal T. Uveitis in Behcet disease: An analysis of 880 patients. Am J Ophthalmol. 2004;138:373-80.

  19. Al-Dhibi H. Macular hole in Behcet’s disease. Indian J Ophtalmol. 2011;59:359-62.

  20. Mujaini A. Frosted branch angiitis, neuroretinitis as initialocular manifestation in Behcet disease. Indian J Ophthalmol. 2011;59:240-1.

  21. Fereydoun D. Diagnosis/Classification criteria for Behcet’s disease. Patholog Res Int. 2012:1-5.

  22. Pimienta M. El fenómeno de patergia. Semin Fund Esp Reumatol. 2009:10. Disponible en: http://www.elsevier.es/es-revista-seminarios-fundacion- espanola-reumatologia-274-articulo-el-fenomeno-patergia- 13140685 [consultado 5 Mar 2015].

  23. Hatemi GS. EULAR recommendations for the management of Behcet disease. Ann Rheum Dis. Dec. 2008;67:1656-62.

  24. Tugal-Tutkun I. Behcet’s uveitis. Middle East Afr J Ophthalmol. 2009; 16:219-24.

  25. Iannuzzi MC. Sarcoidosis. N Engl J Med. 2007;357:2153-65.

  26. James T. Patients with retinal vasculitis rarely suffer from systemic vasculitis. Semin Arthritis Rheum. 2012;41:859-65.

  27. Takase H. Validation of international criteria for the diagnosis of ocular sarcoidosis proposed by the first international workshop on ocular sarcoidosis. Jpn J Ophthalmol. 2010;54:529-36.

  28. Adan A. Uveitis como manifestación inicial de sarcoidosis. Med Clin (Barc). 2004;122(19):748-52.

  29. Herbort CP, Rao NA. International criteria for the diagnosis of ocular sarcoidosis: Results of the first International Workshop On Ocular Sarcoidosis (IWOS). Ocul Immunol Inflamm. 2009;17:160-9.

  30. Herráez OA. La sarcoidosis torácica. Radiología. 2011;53:434-48.

  31. Bradley W. Resolution of chronic ocular sarcoidosis with antimycobacterial therapy. Case Rep Intern Med. 2014;1:5042.

  32. Edelsten C. The ocular and systemic prognosis of patients presenting with sarcoid uveitis. Eye Lond. 1999;13:748-53.

  33. Drake W, Newman L. Sarcoidosis. En: Mason RJ, Broaddus VC, Martin Tr, et al, editores. Murray and Nadel’s Textbook of Respiratory Medicine. 5th ed. Philadelphia, PA: Elsevier Saunders; 2010. p. 59.




2020     |     www.medigraphic.com